Name | Value |
---|---|
Revenues | 611.5K |
Cost of Revenue | 73.5K |
Gross Profit | 538.0K |
Operating Expense | 2,744.9K |
Operating I/L | -2,206.8K |
Other Income/Expense | -710.9K |
Interest Income | 0.0K |
Pretax | -2,917.7K |
Income Tax Expense | 0.0K |
Net Income/Loss | -2,917.7K |
NeurAxis, Inc. is a neuromodulation therapy device company that specializes in the development and commercialization of the IB-Stim, a percutaneous electrical nerve field stimulation system. This system is designed for patients aged 11-18 with functional abdominal pain associated with irritable bowel syndrome. NeurAxis, Inc. primarily targets healthcare facilities such as hospitals and clinics as its customer base. The company generates revenue by selling its neuromodulation therapy devices to these healthcare providers, offering a solution for managing pain associated with irritable bowel syndrome in adolescent patients.